USTEKINUNLth AND CUSELKUMAB TREATMENT RESULTS IN DIFFERENCES IN SERUM IL-17A, IL-17F AND CRP LEVELS IN PSORIATIC ARTHRITIS PATIENTS: A COMPARISON FROM USTEKINUMAB PHASE 3 AND GUSELKUMAB PHASE 2 PROGRAMS

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY(2020)

Cited 0|Views17
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined